biostudies-literatureStruja TSwiss National Science Foundation623https://www.ebi.ac.uk/biostudies/studies/S-EPMC6199355biostudies-literatureUnknown9<b>Background:</b> There is a lack of biochemical markers for early prediction of relapse in patients with Graves' disease [GD], which may help to direct treatment decisions. We assessed the prognostic ability of a high-throughput proton NMR metabolomic profile to predict relapse in a well characterized cohort of GD patients. <b>Methods:</b> Observational study investigating patients presenting with GD at a Swiss hospital endocrine referral center and an associated endocrine outpatient clinic. We measured 227 metabolic markers in the blood of patients before treatment initiation. Main outcome was relapse of hyperthyroidism within 18 months of stopping anti-thyroid drugs. We used ROC analysis with AUC to assess discrimination. <b>Results:</b> Of 69 included patients 18 (26%) patients had a Frontiers in endocrinologyMetabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study.PMC6199355150531Struja TMeier CKutz ABernasconi LNeyer PSchuetz PEckart AMueller BKraenzlin MHuber AfalseMetabolomics for Prediction of Relapse in Graves' Disease: Observational Pilot Study.<b>Background:</b> There is a lack of biochemical markers for early prediction of relapse in patients with Graves' disease [GD], which may help to direct treatment decisions. We assessed the prognostic ability of a high-throughput proton NMR metabolomic profile to predict relapse in a well characterized cohort of GD patients. <b>Methods:</b> Observational study investigating patients presenting with GD at a Swiss hospital endocrine referral center and an associated endocrine outpatient clinic. We measured 227 metabolic markers in the blood of patients before treatment initiation. Main outcome was relapse of hyperthyroidism within 18 months of stopping anti-thyroid drugs. We used ROC analysis with AUC to assess discrimination. <b>Results:</b> Of 69 included patients 18 (26%) patients had a 2018-01-01T00:00:00Z20182025-04-18T23:56:06.681Z2019-03-27T00:05:22ZS-EPMC61993553038630210.3389/fendo.2018.00623